메뉴 건너뛰기
Bulletin du Cancer
Volumn 97, Issue 12, 2010, Pages 1563-1572
Actualities in prostate cancer in ASCO annual meeting 2010;Actualités dans le cancer de la prostate lors de l'ASCO 2010
Author keywords

Cabazitaxel; Chemotherapy; Denosumab; Hormonotherapy; Prostate cancer; Radiotherapy
Indexed keywords

BEVACIZUMAB; CABAZITAXEL; CALCITRIOL; DENOSUMAB; DOCETAXEL; MITOXANTRONE; ZOLEDRONIC ACID; ANTIANDROGEN; ANTINEOPLASTIC AGENT;
EID: 79251473380     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2010.1222     Document Type: Review
Times cited : (1)
References (5)
  • 1
    • 78649352694 scopus 로고    scopus 로고
    • Toremifene to reducefracture risk in men receiving androgen deprivation therapy for prostate cancer
    • Smith MR, Morton RA, Barnette KG, Sieber PR, Malkowicz SB, Rodriguez D, et al. Toremifene to reducefracture risk in men receiving androgen deprivation therapy for prostate cancer. J Urol 2010;184:1316-21.
    • (2010) J. Urol. , vol.184 , pp. 1316-1321
    • Smith, M.R.1    Morton, R.A.2    Barnette, K.G.3    Sieber, P.R.4    Malkowicz, S.B.5    Rodriguez, D.6
  • 2
    • 77951591066 scopus 로고    scopus 로고
    • Phase II multicenter study of abiraterone acetate plus prednisone therapy in patients with docetaxel-treated castrationresistant prostate cancer
    • Danila DC, Morris MJ, de Bono JS, Ryan CJ, Denmeade SR, Smith MR, et al. Phase II multicenter study of abiraterone acetate plus prednisone therapy in patients with docetaxel-treated castrationresistant prostate cancer. J Clin Oncol 2010;28:1496-501.
    • (2010) J. Clin. Oncol. , vol.28 , pp. 1496-1501
    • Danila, D.C.1    Morris, M.J.2    De Bono, J.S.3    Ryan, C.J.4    Denmeade, S.R.5    Smith, M.R.6
  • 3
    • 38049032293 scopus 로고    scopus 로고
    • Intermittent chemotherapy in patients with metastatic androgen-independent prostate cancer: Results from ASCENT, a double-blinded, randomized comparison of high-dose calcitriol plus docetaxel with placebo plus docetaxel
    • Beer TM, Ryan CW, Venner PM, Petrylak DP, Chatta GS, Ruether JD, et al. Intermittent chemotherapy in patients with metastatic androgen-independent prostate cancer: results from ASCENT, a double-blinded, randomized comparison of high-dose calcitriol plus docetaxel with placebo plus docetaxel. Cancer 2008;112:326-30.
    • (2008) Cancer , vol.112 , pp. 326-330
    • Beer, T.M.1    Ryan, C.W.2    Venner, P.M.3    Petrylak, D.P.4    Chatta, G.S.5    Ruether, J.D.6
  • 4
    • 59449102526 scopus 로고    scopus 로고
    • Phase I and pharmacokinetic study of XRP6258 (RPR 116258A), a novel taxane, administered as a 1-hour infusion every three weeks in patients with advanced solid tumors
    • Mita AC, Denis LJ, Rowinsky EK, Debono JS, Goetz AD, Ochoa L, et al. Phase I and pharmacokinetic study of XRP6258 (RPR 116258A), a novel taxane, administered as a 1-hour infusion every three weeks in patients with advanced solid tumors. Clin Cancer Res 2009;15:723-30.
    • (2009) Clin. Cancer Res. , vol.15 , pp. 723-730
    • Mita, A.C.1    Denis, L.J.2    Rowinsky, E.K.3    Debono, J.S.4    Goetz, A.D.5    Ochoa, L.6
  • 5
    • 50849088935 scopus 로고    scopus 로고
    • A multicenter phase II study of XRP6258 administered as a 1-HIV infusion every three weeks in taxaneresistant metastatic breast cancer patients
    • Pivot X, Koralewski P, Hidalgo JL, Chan A, Gonçalves A, Schwartsmann G, et al. A multicenter phase II study of XRP6258 administered as a 1-HIV infusion every three weeks in taxaneresistant metastatic breast cancer patients. Ann Oncol 2008;19:1547-52.
    • (2008) Ann. Oncol. , vol.19 , pp. 1547-1552
    • Pivot, X.1    Koralewski, P.2    Hidalgo, J.L.3    Chan, A.4    Gonçalves, A.5    Schwartsmann, G.6

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.